Diagnos Laboratorium Utama Tbk. vs Panca Anugrah Wisesa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Panca Anugrah Wisesa Tbk. trades at Rp8,000 (market cap 15.29T, 82.6K 24h volume). The key difference: Panca Anugrah Wisesa Tbk. is far larger — about 49.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 82.6K). Which is the better fit depends on your goals.
| DGNS | MGLV | |
|---|---|---|
Market Cap | 310.75B | 15.29T |
Volume | 963.6K | 82.6K |
Lot | 9.64K | 826 |
Turnover | 217.67M | 655.64M |
Average Price | 225.89 | 7,937.56 |
Value | 217.67M | 655.64M |
Indicative Equilibrium Price | 226 | 8,000 |
Indicative Equilibrium Volume | 1K | 400 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Panca Anugrah Wisesa Tbk (the Company) formerly PT Mitra Angrah Investama was established based on Deed of Establishment of Company No. 02 dated June 06, 2012 of Chilmiyati Rufaida, S.H., Notary in Bogor.
Read more on MGLV →